Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
Clinical trial NCT02220738 · TERMINATED
Trial details
- NCT number
- NCT02220738
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-03-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.